{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:31:14Z","timestamp":1759797074783,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ijrobp.2022.10.032","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T02:13:39Z","timestamp":1667873619000},"page":"897-905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Toxicity and Efficacy of Multitarget Thoracic Stereotactic Body Radiation Therapy"],"prefix":"10.1016","volume":"115","author":[{"given":"Eric K.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Poon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yee C.","family":"Ung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee","family":"Korol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyaa H.","family":"Elzibak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darby","family":"Erler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander V.","family":"Louie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2022.10.032_bib0001","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0002","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(18)30896-9","article-title":"Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): A phase 3, open-label, randomised controlled trial","volume":"20","author":"Ball","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0003","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0004","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.26312","article-title":"Evaluation of definitive stereotactic body radiotherapy and outcomes in adults with extracranial oligometastasis","volume":"3","author":"Poon","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0005","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/0284186X.2017.1295166","article-title":"Optimizing SABR delivery for synchronous multiple lung tumors using volumetric-modulated arc therapy","volume":"56","author":"Tekatli","year":"2017","journal-title":"Acta Oncol (Madr)"},{"issue":"suppl 4","key":"10.1016\/j.ijrobp.2022.10.032_bib0006","doi-asserted-by":"crossref","first-page":"S523","DOI":"10.21037\/jtd.2019.01.56","article-title":"Multiple primary lung cancer: A rising challenge","volume":"11","author":"Chen","year":"2019","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0007","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13014-014-0230-6","article-title":"Oligometastasis and oligo-recurrence: More than a mirage","volume":"9","author":"Huang","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0008","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ijrobp.2020.10.004","article-title":"Stereotactic body radiation therapy for mediastinal and hilar lymph node metastases","volume":"109","author":"Shahi","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0009","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.radonc.2018.07.001","article-title":"The safety and effectiveness of stereotactic body radiotherapy for central versus ultracentral lung tumors","volume":"129","author":"Chang","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0010","article-title":"An analysis of clinical toxic effects and quality of life as a function of radiation dose and volume after lung stereotactic body radiation therapy","volume":"6","author":"Devpura","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0011","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijrobp.2012.03.041","article-title":"Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung","volume":"85","author":"Baker","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0012","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0013","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ijrobp.2018.10.008","article-title":"Stereotactic radiation for ultra-central lung tumors: Good idea, or ultra-risky?","volume":"103","author":"Palma","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0014","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1002\/sim.5762","article-title":"Model selection in competing risks regression","volume":"32","author":"Kuk","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1748-717X-7-152","article-title":"Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer","volume":"7","author":"Chang","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0016","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.radonc.2018.02.016","article-title":"Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy","volume":"127","author":"Klement","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0017","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/jamaoncol.2021.0687","article-title":"Evaluation of safety of stereotactic body radiotherapy for the treatment of patients with multiple metastases: Findings from the NRG-BR001 phase 1 trial","volume":"7","author":"Chmura","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0018","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.radonc.2013.04.026","article-title":"Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgery","volume":"107","author":"Griffioen","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0019","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13014-015-0340-9","article-title":"Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules","volume":"10","author":"Owen","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0020","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijrobp.2018.11.028","article-title":"Organs at risk considerations for thoracic stereotactic body radiation therapy: What is safe for lung parenchyma?","volume":"110","author":"Kong","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0021","unstructured":"Trichas M. Stereotactic ablative body radiation therapy (SABR): A resource. Available at:http:\/\/www.academia.edu\/7657886\/Stereotactic_Ablative_Body_Radiation_Therapy_SABR_A_Resource%0Ahttp:\/\/www.actionradiotherapy.org\/wp-content\/uploads\/2014\/12\/UKSABRConsortiumGuidellinesv5.pdf. Accessed April 15, 2022."},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0022","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG Oncology\/RTOG 0813 Trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2020.584756","article-title":"Intermediate dose-volume parameters, not low-dose bath, is superior to predict radiation pneumonitis for lung cancer treated with intensity-modulated radiotherapy","volume":"10","author":"Meng","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0024","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijrobp.2008.04.053","article-title":"Analysis of radiation pneumonitis risk using a generalized Lyman model","volume":"72","author":"Tucker","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0025","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/14737140.2019.1686980","article-title":"Stereotactic body radiotherapy in patients with multiple lung tumors: A focus on lung dosimetric constraints","volume":"19","author":"Milano","year":"2019","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0026","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.radonc.2021.11.030","article-title":"Single-isocenter versus multiple-isocenters for multiple lung metastases: Evaluation of lung dose","volume":"166","author":"van Timmeren","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2015.00213","article-title":"Treatment plan technique and quality for single-isocenter stereotactic ablative radiotherapy of multiple lung lesions with volumetric-modulated arc therapy or intensity-modulated radiosurgery","volume":"5","author":"Quan","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0028","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ijrobp.2017.02.093","article-title":"Stereotactic ablative radiation therapy for pulmonary metastases: Histology, dose, and indication matter","volume":"98","author":"Helou","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0029","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.radonc.2011.05.033","article-title":"Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer","volume":"101","author":"Takeda","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0030","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ijrobp.2015.04.004","article-title":"Colorectal histology is associated with an increased risk of local failure in lung metastases treated with stereotactic ablative radiation therapy","volume":"92","author":"Binkley","year":"2015","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0031","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jrr\/rrv063","article-title":"Stereotactic body radiotherapy for lung metastases as oligo-recurrence: A single institutional study","volume":"57","author":"Aoki","year":"2016","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2022.10.032_bib0032","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3109\/0284186X.2012.681698","article-title":"Potentially curative stereotactic body radiation therapy (SBRT) for single or oligometastasis to the lung","volume":"51","author":"Oh","year":"2012","journal-title":"Acta Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162203509X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162203509X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:03:54Z","timestamp":1759745034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030162203509X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S036030162203509X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.10.032","relation":{},"ISSN":["0360-3016"],"issn-type":[{"type":"print","value":"0360-3016"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicity and Efficacy of Multitarget Thoracic Stereotactic Body Radiation Therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}